Purchase Order HHSF223201610323A

Award Date 7/29/16
Potential Completion Date 7/28/17
Potential Value $97K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Irvine, CA 92612, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Covaris, LLC, a for-profit manufacturer of advanced genomic research tools and technologies. The contract, valued at $27,332.00, is for the delivery of a COVARIS M220 FOCUSED ULTRASONICATOR SYSTEM, accompanying computer software, and starter supplies. The contract has a total small business set-aside designation. Covaris, LLC specializes in Adaptive Focused...
This is a firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Covaris, LLC, a for-profit manufacturer of advanced genomic research tools and technologies based in Woburn, Massachusetts. The contract, valued at $23,858.43, is for the delivery of an ultrasonication machine. The contract has no set-aside designation. Covaris has a long history of securing federal contracts, primarily from National Institutes of Health (NIH) agencies, for the provision of specialized...
This is a federal contract award from the Food and Drug Administration (FDA) to Covaris, LLC, a small business manufacturer of advanced genomic research equipment. The award is for the purchase of a COVARIS S220 SONICATOR, a specialized laboratory instrument used for biomolecule fragmentation and sample preparation, with a firm-fixed price of $23,250.00. The contract has an ultimate completion date of August 29, 2018. Covaris, LLC is a prominent supplier of ultrasonicator equipment and...
This federal contract award, with ID HHSF223201400679P, was granted by the Food and Drug Administration (FDA) to Covaris, LLC, a for-profit manufacturer of advanced tools and technologies for DNA and RNA shearing, sample preparation, and other genomic applications. The $26,483.43 firm-fixed-price purchase order is for the delivery of a "FOCUSED-ULTRASONICATOR - CRITICAL FUNCTION" and was set aside for small businesses. Covaris, LLC has a long history of federal contract and grant...
This firm-fixed-price purchase order valued at $4,500 was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Covaris, LLC, a for-profit manufacturer of advanced genomic sample preparation instruments and accessories. The contract, which had no set-aside designation, was for the delivery of Covaris' ME220, M220, and LE220-plus focused-ultrasonicator systems and related maintenance services to support genomic...
This is a $47,300.00 firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Covaris, LLC, a for-profit manufacturer of advanced genomic research equipment and accessories. The contract is for the delivery of Covaris' desktop focused-ultrasonicator instruments, such as the ME220, M220, and LE220-plus models, as well as related maintenance services. This award does not have...
This is a $89,747.51 firm-fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Covaris, LLC for the delivery of a /E220 FOCUSED-ULTRASONICATOR SYSTEM. The contract has no set-aside designation. Covaris, LLC is a for-profit manufacturer of advanced genomic research tools and technologies, including the Adaptive Focused Acoustics (AFA) ultrasonicator instruments supplied under this award. The ultrasonicator...
This firm-fixed-price purchase order contract was awarded to Covaris, LLC, a for-profit manufacturer of advanced genomics tools and technologies, by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH). The contract, valued at $28,185.00, is for the upgrade of ultrasonicator systems used to support NIAID's genomic research initiatives. Covaris, which has extensive experience providing equipment and maintenance services to...
The Department of Health and Human Services National Institutes of Health National Institute of Environmental Health Sciences awarded a firm fixed-price purchase order contract to Covaris, Inc., a for-profit limited liability company, for the acquisition of an E220 Focused UltraSonicator with water conditioning system and chiller. The total potential value of the contract is $120,935.00. The contract did not have a set-aside designation. According to the pre-solicitation notice, the Covaris E220...
This firm-fixed-price purchase order contract was awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Covaris, LLC, a for-profit manufacturer of advanced genomic research tools and technologies. The contract, valued at $112,351.00, is for the provision of an R230 focused ultrasonicator and accessories. The contract has no set-aside designation. Covaris, LLC is a prominent supplier of ultrasonicator instruments, sample preparation equipment, and...

This is a $96,800 firm-fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Covaris, LLC, a small business manufacturer of advanced genomic research tools and sample preparation equipment. The contract, designated as a total small business set-aside, is for the delivery of Covaris' ME220, M220, and LE220-plus focused-ultrasonicator instruments and related accessories to support the FDA's NEOPREP program. Covaris, which has received numerous prior contracts from federal agencies like the National Institutes of Health and Department of Veterans Affairs for its specialized genomic research equipment, will provide the FDA with these desktop and larger ultrasonicator systems used for precise fragmentation of biomolecules, drug formulations, and other applications. The contract has a period of performance ending on July 28, 2017.

Generated 4/2/25, 10:04 PM